🞂
🞂 Pre-renal cause
Circulatingvolume depletion
Decrease renal blood flow
🞂 Decrease GFR and renal tissue perfusion
🞂 Severe intensic damage of parenchymal cells of kidney
🞂
🞂
PATHOPHYSIOLOGY
12.
Obstruction of ureter
Increasepressure in ureter
🞂 Increase hydrostatic pressure in ducts
and tubules
🞂 Injury to bladder cells and bowels
decreased GFR
If not treatedsevere damage to
Post renal cause
13.
SPECIFIC FEATURES
🞂 oliguria
🞂Anuria
🞂 Uremia-accumulation of nitrogenous waste
🞂 Convulsions
🞂 Hyperkalemia
🞂 hyponatremia
NONSPECIFIC FEATURES
nausea
vomiting
drowsiness
Edema
Rapid breathing
Hypertension/hypotension
hematuria
CLINICAL FEATURES
14.
🞂 History collection
🞂Diarrhoea,vomiting,fever,rash,toxins or drugs
🞂 Physical examination
🞂 Enlarged kidney and distended bladder
🞂 Blood test
🞂 URINALYSIS
🞂 BUN
🞂 cr
🞂 Blood chemistries
🞂 USG
DIAGNOSTIC EVALUATION
15.
🞂 Renal biopsy
🞂A procedure in which tissue
samples are removed (with a needle or during
surgery) from the body for examination under
a microscope.
16.
🞂 The mosteffective management of
ARF is prevention. The treatment of
ARF is directed towards
🞂 Treatment of the underlying causes
🞂 Management of the complications of
renal failure
🞂 Dialysis
MANAGEMENT
17.
🞂 A)Treatment ofthe cause
🞂 Obstruction should be corrected or bypassed
🞂 Infection and shock should be treated
promptly
🞂 Dopamine may improve renal blood flow in
low doses and is effective in various stages
of poor cardiac output
🞂 Dobutamine may improve renal perfusion by
enhancing myocardial contractility
🞂 A catheter should be placed in the bladder to
assess the urine output and to remove the
urine promptly incase of intrinsic kidney
disease
18.
🞂 Correction ofmetabolic acidosis
🞂 It is common in ARF due to catabolism and
inability of the failed kidney to secrete
hydrogen ion
🞂Inj.sodium bicarbonate ,IV ,1-2meq/kg to
be given carefully because it can cause fluid
overload,hypernatremia and hypertension.
🞂 Severe acidosis requires dialysis.
(If sr.bicarbonate levels <12meq/L/pH is <7.2)
B)Management of the
complications
19.
🞂 Management ofHypocalcemia
🞂 It is common in ARF in association with
hyperphosphatemia
🞂 Treatment should be given to lower the
phosphorous level
🞂 Milk and other high phosphorous foods are
severely limited
🞂 Calcium carbonate is given to bind
phosphorous
🞂 Aluminum hydroxide gets previously used
to treat hyperphosphatemia have been
associated with aluminum intoxication
20.
🞂 Management ofHypocalcemia
🞂 It is common in ARF in
association with
hyperphosphatemia
🞂 Treatment should be given to
lower the phosphorous level
🞂 Milk and other high phosphorous
foods are severely limited
🞂 Calcium carbonate is given to
bind phosphorous
🞂 Aluminum hydroxide used to
treat hyperphosphatemia
21.
🞂 Treatment forhyperkalemia
🞂 Potassium containing fluids and diet
should be restricted until the renal function is
Improved.It should immediately be treated with
drugs
🞂 Calcium gluconate 10% solution 0.5 ml/kg IV to
be given over 10 minute.A variation of 20 beats
requires stopping the infusion
🞂 Sodium bicarbonate 7.5 % solution 1-3 MEq/kg
IV can be given
🞂 Glucose 25% solution, 2ml/kg/ with insulin 0.1
units/ kg to be given IV over 1 hour.The patient
should be closely monitored for hypoglycemia
🞂 Kayexalate 1 g/kg should be given orally or by
retention enema.
22.
🞂 1.close attentionto the intake of fluid
and electrolytes
🞂 2.provision of proper nutrition
🞂 3.preventing complications
🞂 4.providing adequate rest
🞂 5. providing education and support to
family members.
Nursing management
🞂Early signs
🞂 Lackof energy
🞂 Fatigue on exertion
🞂 Pallor,anemia
🞂 Elevated BP
Clinical features
29.
Late signs
🞂 Decreasedappetite
🞂 Less interest in normal activities
🞂 Increased /decreased urine output
🞂 Muddy appearence of skin
🞂 Headache,muscular cramps and
nausea
30.
🞂 Weight loss
🞂Facial edema
🞂 Malaise
🞂 Bone or joint pain
🞂 Growth retardation
🞂 Dryness or itching on skin
🞂 Bruised skin
🞂 Sensory or motor loss
🞂 Amenorrhoea in adolescent girls
🞂 Dental defects-
discoloration,malocclusion
Other features